[CLDX] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -6.09%
YoY- -14.91%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 1,874 2,220 1,389 1,303 1,790 1,026 2,178 -9.49%
PBT -32,307 -29,598 -31,952 -34,673 -32,684 -31,980 -32,359 -0.10%
Tax -5,090 -790 -828 -2,062 836 -782 -782 246.63%
NP -32,307 -29,598 -31,952 -34,673 -32,684 -31,980 -32,359 -0.10%
Tax Rate - - - - - - - -
Total Cost 34,181 31,818 33,341 35,976 34,474 33,006 34,537 -0.68%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -1,723.96 -1,333.24 -2,300.36 -2,661.01 -1,825.92 -3,116.96 -1,485.72 10.37%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -4.49 -4.41 -4.85 -5.27 -4.97 -4.87 -4.93 -6.01%
EPS Diluted -4.49 -4.41 -4.85 -5.27 -4.97 -4.87 -4.93 -6.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.